Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Fatigued patients with multiple sclerosis can be discriminated from healthy controls by the recordings of a newly developed measurement system (FAMOS): a pilot study.
Laquinimod, a once-daily oral drug in development for the treatment of relapsing-remitting multiple sclerosis.
Energy conservation for fatigue management in multiple sclerosis: a pilot randomized controlled trial.
A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis.
Neuromyelitis Optica: Potential Roles for Intravenous Immunoglobulin.
Multiple Sclerosis: Changes in Microarchitecture of White Matter Tracts after Training with a Video Game Balance Board.
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43.
Research Advances in Biomarkers for Demyelinating Optic Neuritis.
Pathogenic CD8 T cells in multiple sclerosis and its experimental models.
Mast Cells are Important Modifiers of Autoimmune Disease: With so Much Evidence, Why is There Still Controversy?
Xavier Montalban: a pioneer in understanding multiple sclerosis.
Simvastatin: two decades in a circle.
Parkinsonism in multiple sclerosis patients: A casual or causal association?
The mechanism of action of interferon-β in relapsing multiple sclerosis.
FTY720 attenuates excitotoxicity and neuroinflammation.
ACTH gel in the treatment of multiple sclerosis exacerbation: a case study.
Biological and nonbiological complex drugs for multiple sclerosis in Latin America: regulations and risk management.
A Surprisingly Low Prevalence of Demonstrable Stress Urinary Incontinence and Pelvic Organ Prolapse in Women with Multiple Sclerosis Followed at a Tertiary Neurogenic Bladder Clinic.
A rare presentation of atypical demyelination: tumefactive multiple sclerosis causing Gerstmann's syndrome.
Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients.
Delta-9-tetrahydrocannabinol + cannabidiol. A reasonable option for some patients with multiple sclerosis.
Origin and evolution of deep brain stimulation.
Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota.
Current status of myelin replacement therapies in multiple sclerosis.
Network-Based Multiple Sclerosis Pathway Analysis with GWAS Data from 15,000 Cases and 30,000 Controls.

Pages